Senate, White House working on drug pricing

On Tuesday, the Senate Health, Education, Labor and Pensions (HELP) Committee held the first of three planned hearings on drug pricing. Lamar Alexander (R-Ky.), the committee's chair, characterized the hearings as a bipartisan fact-finding exercise. He did not suggest that they will lead to legislation.

Separately, the Trump administration continues to assemble plans to address drug pricing. Members of BIO’s board of directors met with HHS Secretary Tom Price on Monday to make the industry’s case for pro-innovation policies...